Track topics on Twitter Track topics that are important to you
The hiked medicines include psoriasis drug Stelara, blood thinner Xarelto and prostate cancer therapy Zytiga, with the majority of increases reaching between 6% and 7%.
Despite the move, J&J spokesman Ernie Knewitz gave assurances that the company has no plans for any further price increases this year.NEXT ARTICLE
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Psoriasis is a common skin condition affecting 2-3% of the population of the United Kingdom, where the skins replacement process is sped taking 2-6 days instead of the usual 21 - 28 days for the replacement of skin cells. Patients experience an accumulat...